Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Jun-24 4:53 PM View:  | Nuvalent, Inc. (NUVL) | 12-Jun-24 | Grant | 2,499 | -- | -- | < 1% 2.7M to 2.7M | |
| 29-Mar-24 5:15 PM View: | Nuvalent, Inc. (NUVL) | 27-Mar-24 | Private Sale | 880,000 | $72.77 | $64,036,000.00 | (25%) 3.58M to 2.7M | |
| 10-Aug-23 4:31 PM View: | Dynavax Technologies Corp. (DVAX) | 08-Aug-23 | Market Sale | 1,500,000 | $14.39 | $21,585,000.00 | (62%) 2.43M to 925.71K | (< 1%) |
| 12-Jun-23 5:25 PM View: | Mersana Therapeutics, Inc. (MRSN) | 08-Jun-23 | Grant | 14,467 | -- | -- | < 1% 8.66M to 8.68M | |
| 31-May-23 5:43 PM View: | Dynavax Technologies Corp. (DVAX) | 26-May-23 | Grant | 5,357 | -- | -- | < 1% 2.92M to 2.93M | |
| 19-May-23 4:30 PM View: | Dynavax Technologies Corp. (DVAX) | 18-May-23 | Sale | 1,000,000 | $10.55 | $10,550,000.00 | (26%) 3.92M to 2.92M | |
| 08-Dec-22 4:41 PM View: | Dynavax Technologies Corp. (DVAX) | 06-Dec-22 | Sale | 1,500,000 | $11.60 | $17,400,000.00 | (28%) 5.42M to 3.92M | |
| 03-Nov-22 4:15 PM View: | Nuvalent, Inc. (NUVL) | 03-Nov-22 | Purchase | 149,253 | $33.50 | $4,999,980.00 | 4% 3.43M to 3.58M | |
| 17-Aug-22 5:17 PM View: | Dynavax Technologies Corp. (DVAX) | 15-Aug-22 | Market Sale | 3,000,000 | $14.68 | $44,040,000.00 | (36%) 8.41M to 5.42M | 2% |
| 02-Jun-22 6:17 PM View: | Mersana Therapeutics, Inc. (MRSN) | 02-Jun-22 | Purchase | 14,760 | $3.20 | $47,181.80 | < 1% 8.65M to 8.66M | |
| 02-Jun-22 6:17 PM View: | Mersana Therapeutics, Inc. (MRSN) | 31-May-22 | Private Purchase | 80,759 | $3.28 | $264,776.00 | < 1% 8.57M to 8.65M | |
| 26-May-22 6:02 PM View: | Mersana Therapeutics, Inc. (MRSN) | 26-May-22 | Purchase | 75,000 | $3.19 | $238,942.00 | < 1% 8.49M to 8.57M | |
| 26-May-22 6:02 PM View: | Mersana Therapeutics, Inc. (MRSN) | 25-May-22 | Purchase | 90,155 | $3.17 | $286,242.00 | 1% 8.4M to 8.49M | |
| 26-May-22 6:02 PM View: | Mersana Therapeutics, Inc. (MRSN) | 24-May-22 | Private Purchase | 100,000 | $3.29 | $328,990.00 | 1% 8.3M to 8.4M | |
| 23-May-22 5:49 PM View: | Mersana Therapeutics, Inc. (MRSN) | 23-May-22 | Purchase | 15,599 | $3.35 | $52,247.30 | < 1% 8.29M to 8.3M | |
| 23-May-22 5:49 PM View: | Mersana Therapeutics, Inc. (MRSN) | 20-May-22 | Purchase | 100,000 | $3.46 | $345,570.00 | 1% 8.19M to 8.29M | |
| 23-May-22 5:49 PM View: | Mersana Therapeutics, Inc. (MRSN) | 19-May-22 | Private Purchase | 100,000 | $3.49 | $348,620.00 | 1% 8.09M to 8.19M | |
| 18-May-22 6:19 PM View: | Mersana Therapeutics, Inc. (MRSN) | 18-May-22 | Purchase | 211,268 | $3.35 | $707,262.00 | 3% 7.88M to 8.09M | |
| 18-May-22 6:19 PM View: | Mersana Therapeutics, Inc. (MRSN) | 17-May-22 | Purchase | 3,440 | $3.18 | $10,952.30 | < 1% 7.87M to 7.88M | |
| 18-May-22 6:19 PM View: | Mersana Therapeutics, Inc. (MRSN) | 16-May-22 | Private Purchase | 135,292 | $3.10 | $419,446.00 | 2% 7.74M to 7.87M | |
| 14-Apr-22 4:59 PM View: | Mersana Therapeutics, Inc. (MRSN) | 13-Apr-22 | Private Purchase | 617,284 | $4.05 | $2,500,000.00 | 9% 7.12M to 7.74M | |
| 13-Apr-22 6:27 PM View: | Mersana Therapeutics, Inc. (MRSN) | 12-Apr-22 | Private Purchase | 598,086 | $4.18 | $2,499,880.00 | 9% 6.52M to 7.12M | |
| 08-Feb-22 5:04 PM View: | Mersana Therapeutics, Inc. (MRSN) | 07-Feb-22 | Private Purchase | 1,136,360 | $4.42 | $5,022,720.00 | 21% 5.39M to 6.52M | |
| 04-Jan-22 6:16 PM View: | Mersana Therapeutics, Inc. (MRSN) | 30-Dec-21 | Market Purchase | 815,000 | $6.15 | $5,012,250.00 | 18% 4.57M to 5.39M | 8% |
| 03-Jan-22 6:28 PM View: | Mersana Therapeutics, Inc. (MRSN) | 29-Dec-21 | Market Purchase | 875,000 | $5.75 | $5,031,250.00 | 24% 3.7M to 4.57M | 11% |
| 27-Aug-21 8:07 PM View: | Dynavax Technologies Corp. (DVAX) | 27-Aug-21 | Conversion | 1,891,000 | -- | -- | 22% 8.52M to 10.41M | |
| 27-Aug-21 8:07 PM View: | Dynavax Technologies Corp. (DVAX) | 27-Aug-21 | Market Sale | 2,000,000 | $16.22 | $32,440,000.00 | (19%) 10.41M to 8.41M | |
| 11-Aug-21 6:26 PM View: | Dynavax Technologies Corp. (DVAX) | 09-Aug-21 | Conversion | 2,249,000 | -- | -- | 26% 8.53M to 10.77M | |
| 11-Aug-21 6:26 PM View: | Dynavax Technologies Corp. (DVAX) | 09-Aug-21 | Market Sale | 2,250,000 | $10.80 | $24,300,000.00 | (21%) 10.77M to 8.52M | |
| 04-Aug-21 5:12 PM View: | Nuvalent, Inc. (NUVL) | 02-Aug-21 | Conversion | 2,693,010 | -- | -- | 100% 0 to 2.69M | |
| 04-Aug-21 5:12 PM View: | Nuvalent, Inc. (NUVL) | 02-Aug-21 | Purchase | 735,000 | $17.00 | $12,495,000.00 | 27% 2.69M to 3.43M | |
| 12-Jan-21 7:29 PM View: | Mersana Therapeutics, Inc. (MRSN) | 12-Jan-21 | Market Purchase | 75,000 | $18.16 | $1,362,000.00 | 2% 3.62M to 3.7M | < 1% |
| 12-Jan-21 7:29 PM View: | Mersana Therapeutics, Inc. (MRSN) | 11-Jan-21 | Market Purchase | 75,000 | $18.52 | $1,389,000.00 | 2% 3.55M to 3.62M | (1%) |
| 12-Jan-21 7:29 PM View: | Mersana Therapeutics, Inc. (MRSN) | 08-Jan-21 | Market Purchase | 100,000 | $18.39 | $1,839,000.00 | 3% 3.45M to 3.55M | (< 1%) |
| 03-Nov-20 9:36 PM View: | Atea Pharmaceuticals, Inc. (AVIR) | 03-Nov-20 | Conversion | 5,365,660 | -- | -- | 100% 0 to 5.37M | |
| 03-Nov-20 9:36 PM View: | Atea Pharmaceuticals, Inc. (AVIR) | 03-Nov-20 | Purchase | 250,000 | $24.00 | $6,000,000.00 | 5% 5.37M to 5.62M | |
| 26-Oct-20 4:30 PM View: | Bcls Acquisition Corp. (BLSA) | 26-Oct-20 | Grant Duplicate | 487,500 | $10.00 | $4,875,000.00 | 100% 0 to 487.5K | |
| 28-May-20 5:13 PM View: | Dynavax Technologies Corp. (DVAX) | 27-May-20 | Market Purchase | 1,000,000 | $5.00 | $5,000,000.00 | 13% 7.53M to 8.53M | |
| 09-Apr-20 4:11 PM View: | Mersana Therapeutics, Inc. (MRSN) | 07-Apr-20 | Market Purchase | 3,445,670 | $5.99 | $20,649,500.00 | 100% 0 to 3.45M | 347% |
| 06-Feb-19 4:41 PM View: | Editas Medicine, Inc. (EDIT) | 04-Feb-19 | Option Exercise | 6,895 | $6.48 | $44,679.60 | 100% 0 to 6.89K | |
| 06-Feb-19 4:41 PM View: | Editas Medicine, Inc. (EDIT) | 04-Feb-19 | Market Option Sale (Planned) | 6,895 | $21.39 | $147,484.00 | (100%) 6.89K to 0 | (282%) |
| 08-Jan-19 5:36 PM View: | Editas Medicine, Inc. (EDIT) | 04-Jan-19 | Option Exercise | 7,000 | $6.48 | $45,360.00 | 100% 0 to 7.0K | |
| 08-Jan-19 5:36 PM View: | Editas Medicine, Inc. (EDIT) | 04-Jan-19 | Market Option Sale (Planned) | 7,000 | $22.48 | $157,360.00 | (100%) 7.0K to 0 | (263%) |
| 27-Nov-18 4:25 PM View: | Editas Medicine, Inc. (EDIT) | 23-Nov-18 | Option Exercise | 5,284 | $6.48 | $34,240.30 | 100% 0 to 5.28K | |
| 27-Nov-18 4:25 PM View: | Editas Medicine, Inc. (EDIT) | 23-Nov-18 | Market Option Sale (Planned) | 5,284 | $28.15 | $148,739.00 | (100%) 5.28K to 0 | (190%) |
| 30-Oct-18 5:05 PM View: | Editas Medicine, Inc. (EDIT) | 26-Oct-18 | Option Exercise | 6,000 | $6.48 | $38,880.00 | 100% 0 to 6.0K | |
| 30-Oct-18 5:05 PM View: | Editas Medicine, Inc. (EDIT) | 26-Oct-18 | Market Option Sale (Planned) | 6,000 | $25.70 | $154,200.00 | (100%) 6.0K to 0 | (218%) |
| 02-Oct-18 4:02 PM View: | Editas Medicine, Inc. (EDIT) | 28-Sep-18 | Option Exercise | 8,000 | $6.48 | $51,840.00 | 100% 0 to 8.0K | |
| 02-Oct-18 4:02 PM View: | Editas Medicine, Inc. (EDIT) | 28-Sep-18 | Market Option Sale (Planned) | 8,000 | $32.08 | $256,640.00 | (100%) 8.0K to 0 | (154%) |
| 05-Sep-18 4:04 PM View: | Editas Medicine, Inc. (EDIT) | 31-Aug-18 | Option Exercise | 10,000 | $6.48 | $64,800.00 | 100% 0 to 10.0K |